trending Market Intelligence /marketintelligence/en/news-insights/trending/_z8ioo0orS4CR6b_puNTNQ2 content esgSubNav
In This List

Karyopharm CFO steps down

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Karyopharm CFO steps down

Justin Renz stepped down as Karyopharm Therapeutics Inc.'s CFO, executive vice president and treasurer, effective April 3.

Renz, who resigned to pursue other opportunities, will continue to serve the company in an advisory capacity in order to ensure a smooth transition.

Karyopharm has started a search process for the selection and appointment of a new CFO.

In the interim, the vice president of finance, Michael Todisco, will lead the company's internal finance function.